Blue Fin Capital, Inc. Abbott Laboratories Transaction History
Blue Fin Capital, Inc.
- $517 Million
- Q3 2024
A detailed history of Blue Fin Capital, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 17,466 shares of ABT stock, worth $2.01 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
17,466
Previous 17,492
0.15%
Holding current value
$2.01 Million
Previous $1.82 Million
9.58%
% of portfolio
0.39%
Previous 0.37%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.4 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.84 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.58 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.14 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $202B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...